Qube Research & Technologies (QRT)
ALXN

Qube Research & Technologies (QRT)’s Alexion Pharmaceuticals ALXN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-117,649
Closed -$21.6M – 3043
2021
Q2 		$21.6M Buy
117,649
+56,167
+91% +$9.64M 0.25% 79
2021
Q1 		$9.4M Buy
61,482
+24,318
+65% +$3.76M 0.15% 146
2020
Q4 		$5.81M Buy
+37,164
New +$4.78M 0.08% 273
2020
Q3 		– Sell
-78,957
Closed -$8.86M – 2259
2020
Q2 		$8.86M Buy
78,957
+60,089
+318% +$6.38M 0.13% 196
2020
Q1 		$1.69M Sell
18,868
-28,490
-60% -$2.8M 0.07% 261
2019
Q4 		$5.12M Buy
47,358
+37,362
+374% +$4M 0.16% 121
2019
Q3 		$979K Buy
+9,996
New +$1.13M 0.65% 31
2019
Q2 		– Sell
-4,877
Closed -$659K – 597
2019
Q1 		$659K Buy
4,877
+1,466
+43% +$182K 0.09% 290
2018
Q4 		$332K Sell
3,411
-2,376
-41% -$281K 0.14% 181
2018
Q3 		$804K Buy
+5,787
New +$726K 0.11% 148
2018
Q2 		– Sell
-1,138
Closed -$126K – 946
2018
Q1 		$126K Buy
+1,138
New +$136K 0.05% 207

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ALXN Position: Q3 2021 in Review

Qube Research & Technologies (QRT) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 117,649 shares — an estimated $21.6M sold.

Qube Research & Technologies (QRT) first reported a position in ALXN in Q1 2018 and held it in 11 quarters. The position peaked at $21.6M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Qube Research & Technologies (QRT) reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 117,649 Alexion Pharmaceuticals shares in Q3 2021, an estimated $21.6M.
  • Qube Research & Technologies (QRT) first reported a position in Alexion Pharmaceuticals in Q1 2018 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Alexion Pharmaceuticals position peaked at $21.6M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2021, filed 12 Nov 2021.